Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,641 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

NCT06764238

Conditions
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
View all 27 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)

NCT07082686

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • West China Hospital of Sichuan University Chengdu, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 29 locations
View Trial Details
Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
View all 127 locations
View Trial Details
Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

NCT07069699

Conditions
Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

NCT06091865

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California (UC) Davis Sacramento, California, United States
View all 168 locations
View Trial Details
Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

NCT06072131

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California, San Francisco Fresno Clovis, California, United States
  • University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600 Santa Monica, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute Pembroke Pines, Florida, United States
View all 69 locations
View Trial Details

Related conditions